(Q36314791)

13 August 2017

1 reference

title

Role of nanobiotechnology in developing personalized medicine for cancer (English)

1 reference

13 August 2017

main subject

personalized medicine

1 reference

K K Jain

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Technology in Cancer Research and Treatment

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

645-650

1 reference

Personalised medicine for cancer: from drug development into clinical practice

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Nanotechnology in clinical laboratory diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Protease-activated quantum dot probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Role of oncoproteomics in the personalized management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Advanced nanoscale separations and mass spectrometry for sensitive high-throughput proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

The role of nanobiotechnology in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Mesoporous membrane device for asymmetric biosensing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Nanobodies as novel agents for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Nanotechnology-based drug delivery for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400608

10.1177/153303460500400608

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference